Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 8 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2023 Filed Feb 13, 2023 22:01 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantRestricted Stock Units · Derivative | 98,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004934 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,710 Underlying: Common Stock · 98,710 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:59 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 322,110 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004928 · form4.xml · derivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,110 Underlying: Common Stock · 322,110 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:59 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 107,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004928 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,370 Underlying: Common Stock · 107,370 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:00 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantStock Option (Right to Buy) · Derivative | 294,810 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004931 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,810 Underlying: Common Stock · 294,810 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:00 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantRestricted Stock Units · Derivative | 98,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004931 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,270 Underlying: Common Stock · 98,270 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantStock Option (Right to Buy) · Derivative | 301,100 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004926 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,100 Underlying: Common Stock · 301,100 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantRestricted Stock Units · Derivative | 100,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004926 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,370 Underlying: Common Stock · 100,370 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:56 UTC |
WADE JEFFREY LPresident and CFO
|
GrantStock Option (Right to Buy) · Derivative | 442,030 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004923 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,030 Underlying: Common Stock · 442,030 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:56 UTC |
WADE JEFFREY LPresident and CFO
|
GrantRestricted Stock Units · Derivative | 147,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004923 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,340 Underlying: Common Stock · 147,340 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:55 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,083,440 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004919 · form4.xml · derivative · entry 2 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083,440 Underlying: Common Stock · 1,083,440 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:55 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 361,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004919 · form4.xml · derivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,150 Underlying: Common Stock · 361,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:46 UTC |
Artal International S.C.A.Director · 10% owner
Wittouck AmauryDirector · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
Invus Public Equities, L.P.Director · 10% owner
Invus, L.P.Director · 10% owner
Invus Public Equities Advisors, LLCDirector · 10% owner
Invus Advisors, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 2,426,070 | $2.50 | $6,065,175.00 |
DisclosureSEC source: 0000899243-22-028108 · doc4.xml · nonDerivative · entry 1 Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Wittouck Amaury · CIK 0001841311 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Invus Public Equities, L.P. · CIK 0001340097 · Director · 10% owner Invus, L.P. · CIK 0001404570 · Director · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · Director · 10% owner Invus Advisors, L.L.C. · CIK 0001404553 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 50,859,331 F1 · kind: Pursuant to a purchase agreement dated July 27, 2022, between Artal International S.C.A. and the Issuer, on August 5, 2022, Artal International S.C.A. purchased an additional 2,426,070 shares of common stock, $0.001 par value per share (the "Issuer Common Stock"), following the full exercise by the underwriters of a concurrent public offering of their option to purchase additional shares of Issuer Common Stock. F2 · ownership.nature: These securities are directly held by Artal International S.C.A. F5 · ownership.nature: Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. The managing partner of Artal International S.C.A. is Artal International Management S.A. The parent company of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting. F6 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:48 UTC |
Invus US Partners LLCDirector · 10% owner
Ulys, L.L.C.Director · 10% owner
DEBBANE RAYMONDDirector · 10% owner
|
PurchaseCommon Stock | 147,390 | $2.50 | $368,475.00 |
DisclosureSEC source: 0000899243-22-028113 · doc4.xml · nonDerivative · entry 1 Invus US Partners LLC · CIK 0001839806 · Director · 10% owner Ulys, L.L.C. · CIK 0001340098 · Director · 10% owner DEBBANE RAYMOND · CIK 0001053890 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,451,204 F1 · kind: Pursuant to a purchase agreement dated July 27, 2022, between Invus US Partners LLC and the Issuer, on August 5, 2022, Invus US Partners LLC purchased an additional 147,390 shares of common stock, $0.001 par value per share (the "Issuer Common Stock"), following the full exercise by the underwriters of a concurrent public offering of their option to purchase additional shares of Issuer Common Stock. F2 · ownership.nature: These securities are directly held by Invus US Partners LLC F4 · ownership.nature: Ulys, L.L.C. is the general partner of Invus US Partners LLC, and Mr. Raymond Debbane is the sole member of Ulys, L.L.C. F5 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| August 01, 2022 Filed Aug 1, 2022 20:15 UTC |
Artal International S.C.A.Director · 10% owner
Wittouck AmauryDirector · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
Invus Public Equities, L.P.Director · 10% owner
Invus, L.P.Director · 10% owner
Invus Public Equities Advisors, LLCDirector · 10% owner
Invus Advisors, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 16,173,800 | $2.50 | $40,434,500.00 |
DisclosureSEC source: 0000899243-22-027156 · doc4.xml · nonDerivative · entry 1 Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Wittouck Amaury · CIK 0001841311 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Invus Public Equities, L.P. · CIK 0001340097 · Director · 10% owner Invus, L.P. · CIK 0001404570 · Director · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · Director · 10% owner Invus Advisors, L.L.C. · CIK 0001404553 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 48,433,261 F1 · kind: On July 27, 2022, Artal International S.C.A. entered into a purchase agreement with the Issuer pursuant to which Artal International S.C.A. agreed to purchase 16,173,800 shares of common stock, $0.001 par value per share (the "Issuer Common Stock"), of the Issuer at a price of $2.50 per share. The purchase closed on August 1, 2022. F2 · ownership.nature: These securities are directly held by Artal International S.C.A. F5 · ownership.nature: Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. The managing partner of Artal International S.C.A. is Artal International Management S.A. The parent company of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting. F6 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| August 01, 2022 Filed Aug 1, 2022 20:13 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 982,600 | $2.50 | $2,456,500.00 |
DisclosureSEC source: 0001127602-22-020005 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Invus US Partners LLC Disclosed balance after: 5,303,814 Read SEC document |
| August 01, 2022 Filed Aug 1, 2022 20:15 UTC |
Invus US Partners LLCDirector · 10% owner
Ulys, L.L.C.Director · 10% owner
DEBBANE RAYMONDDirector · 10% owner
|
PurchaseCommon Stock | 982,600 | $2.50 | $2,456,500.00 |
DisclosureSEC source: 0000899243-22-027157 · doc4.xml · nonDerivative · entry 1 Invus US Partners LLC · CIK 0001839806 · Director · 10% owner Ulys, L.L.C. · CIK 0001340098 · Director · 10% owner DEBBANE RAYMOND · CIK 0001053890 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,303,814 F1 · kind: On July 27, 2022, Invus US Partners LLC entered into a purchase agreement with the Issuer pursuant to which Invus US Partners LLC agreed to purchase 982,600 shares of common stock, $0.001 par value per share (the "Issuer Common Stock") of the Issuer at a price of $2.50 per share. The purchase closed on August 1, 2022. F2 · ownership.nature: These securities are directly held by Invus US Partners LLC F4 · ownership.nature: Ulys, L.L.C. is the general partner of Invus US Partners LLC, and Mr. Raymond Debbane is the sole member of Ulys, L.L.C. F5 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:18 UTC |
Swain Judith LDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015379 · form4.xml · derivative · entry 2 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:18 UTC |
Swain Judith LDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015379 · form4.xml · derivative · entry 1 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:17 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015376 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:17 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015376 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:16 UTC |
NIES ALAN SDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015374 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:16 UTC |
NIES ALAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015374 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:15 UTC |
Palantoni FrankDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015372 · form4.xml · derivative · entry 2 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:15 UTC |
Palantoni FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015372 · form4.xml · derivative · entry 1 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:14 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015370 · form4.xml · derivative · entry 2 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:14 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015370 · form4.xml · derivative · entry 1 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:14 UTC |
DEBBANE RAYMONDDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015368 · form4.xml · derivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:14 UTC |
DEBBANE RAYMONDDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015368 · form4.xml · derivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:13 UTC |
BARKER SAM LDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015367 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:13 UTC |
BARKER SAM LDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015367 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:12 UTC |
Amouyal PhilippeDirector
|
GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015365 · form4.xml · derivative · entry 2 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:12 UTC |
Amouyal PhilippeDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015365 · form4.xml · derivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:22 UTC |
Swain Judith LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012835 · form4.xml · derivative · entry 2 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:22 UTC |
Swain Judith LDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012835 · form4.xml · nonDerivative · entry 1 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:18 UTC |
SOBECKI CHRISTOPHER JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012833 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:18 UTC |
SOBECKI CHRISTOPHER JDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012833 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:17 UTC |
Palantoni FrankDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012832 · form4.xml · derivative · entry 2 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:17 UTC |
Palantoni FrankDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012832 · form4.xml · nonDerivative · entry 1 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:16 UTC |
NIES ALAN SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012830 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:16 UTC |
NIES ALAN SDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012830 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:15 UTC |
LEFKOWITZ ROBERT J MDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012829 · form4.xml · derivative · entry 2 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:15 UTC |
LEFKOWITZ ROBERT J MDDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012829 · form4.xml · nonDerivative · entry 1 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:14 UTC |
DEBBANE RAYMONDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012827 · form4.xml · derivative · entry 3 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:14 UTC |
DEBBANE RAYMONDDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012827 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:12 UTC |
BARKER SAM LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012825 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:12 UTC |
BARKER SAM LDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012825 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:11 UTC |
Amouyal PhilippeDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012824 · form4.xml · derivative · entry 2 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:11 UTC |
Amouyal PhilippeDirector
|
Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012824 · form4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC |
Alexander KristenVP, Finance and Accounting
|
Exercise / conversionRestricted Stock Units · Derivative | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · derivative · entry 7 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 2,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC |
Alexander KristenVP, Finance and Accounting
|
Exercise / conversionRestricted Stock Units · Derivative | 5,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · derivative · entry 6 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 5,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.